CClinicalTrials.gg
Not yet recruitingNCT06674083Updated Nov 6, 2024

Reliability of the Gyko Inertial Sensor System in Evaluating Jumping and Postural Stability Parameters in Healthy Adults

An observational study in Assessment, Self and Sports Physical Therapy, sponsored by Hacettepe University. Not yet recruiting. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-06.

Sponsored by Hacettepe University · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
55
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The aim of the study is to examine the Gyko inertial sensor system in healthy adults. In the study, jump and postural control parameters are assessed with a one-week interval. To evaluate intra-rater reliability, ICC, SEM, and MDC values will be calculated.

Read the detailed description

The Gyko inertial sensor system is a lightweight and portable device that applies protocols for assessing and monitoring joint function, muscle strength, jump, and postural stability parameters during the rehabilitation of a specific musculoskeletal region. Previous studies have evaluated the validity of Gyko in assessing vertical jump height in female sub-elite soccer players and its reliability in evaluating postural stability in healthy, non-athletic adults. However, the findings regarding both the validity and reliability of the device have been limited.

Our aim in this study is to evaluate the reliability of the Gyko inertial sensor system, an affordable and accessible tool that facilitates the assessment and monitoring of jump and postural stability parameters in healthy adults. If the study confirms the reliability of the Gyko device in evaluating these parameters, it could be used by clinicians, therapists, researchers, and/or coaches as a targeted alternative to gold standard methods for assessing jump and postural stability parameters in healthy adults.

Hypotheses:

H0: The use of the Gyko inertial sensor system is not reliable for assessing jump and postural control parameters in healthy adults.

H1: The use of the Gyko inertial sensor system is reliable for assessing jump performance in healthy adults.

H2: The use of the Gyko inertial sensor system is reliable for assessing postural control in healthy adults.

02

Conditions studied

  • Assessment, Self
  • Sports Physical Therapy

Keywords

  • Gyko inertial sensor system
  • Jump
  • Reliability
  • Postural stability
03

In context

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Sample size calculations were based on the ICC (0.81-0.87) data for jump parameters obtained from the reference study. Accordingly, the minimum acceptable reliability (ICC) (ρ0) was set at 0.70, with the expected reliability (ICC) (ρ1) at 0.85, considering 80% power and a significance level of 0.05. As a result of the power analysis, it was determined that at least 50 participants should be included in the study. Considering a 10% possibility of separation in test-retest for the participants, it was decided to include 55 individuals.

Inclusion criteria

  • being between the ages of 18 and 35
  • having no balance issues (such as vertigo) that could affect assessments
  • having no health problems that would interfere with understanding the assessments.

Exclusion criteria

Exclusion Criteria:

  • Having known neurological, rheumatological, or musculoskeletal system problems.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
55 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthy adults

    Inclusion criteria for participants are as follows: being between the ages of 18 and 30, having no balance issues (such as vertigo) that could affect assessments, and having no health problems that would interfere with understanding the assessments.

06

What researchers measure

Primary outcomes

  1. The reliability of the jump and postural stability reliability with Gyko inertial system

    Assessments will be repeated one week apart to evaluate the reliability of the Gyko inertial system in postural stability and jump performance parameters. Jump and postural stability assessment with Gyko inertial system.

    Time frame: two weeks

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06674083
Lead sponsor
Hacettepe University
Responsible party
Birgül Dıngırdan (Research Assisstant, Hacettepe University) — Principal investigator
First posted
Nov 5, 2024
Start date
Feb 2025 (estimated)
Primary completion
Apr 2025 (estimated)
Completion
May 2025 (estimated)
Last update
Nov 6, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion